[HTML][HTML] Metachronous brain tumor in 177Lu-PSMA scan in a patient with metastatic castration resistant prostate cancer mimicking disease progression
E Pirayesh, M Tavakoli - Molecular Imaging and Radionuclide …, 2023 - ncbi.nlm.nih.gov
A 66-year old man known case of metastatic castration resistant prostate cancer underwent
successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen. On the last …
successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen. On the last …
Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression
E Pirayesh, M Tavakoli - 2023 - mirt.tsnmjournals.org
ABSTRACT A 66-year old man known case of metastatic castration resistant prostate cancer
underwent successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen …
underwent successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen …
Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression.
E Pirayesh, M Tavakoli - Molecular Imaging and Radionuclide …, 2023 - europepmc.org
A 66-year old man known case of metastatic castration resistant prostate cancer underwent
successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen. On the last …
successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen. On the last …
Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression
E Pirayesh, M Tavakoli - Molecular imaging and …, 2023 - pubmed.ncbi.nlm.nih.gov
A 66-year old man known case of metastatic castration resistant prostate cancer underwent
successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen. On the last …
successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen. On the last …
Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression
E Pirayesh, M Tavakoli - 2023 - mirt.tsnmjournals.org
ABSTRACT A 66-year old man known case of metastatic castration resistant prostate cancer
underwent successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen …
underwent successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen …
Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression.
E Pirayesh, M Tavakoli - Molecular Imaging & Radionuclide …, 2023 - search.ebscohost.com
A 66-year old man known case of metastatic castration resistant prostate cancer underwent
successful 6 cycles treatment with 177Lu-prostatespecific membrane antigen. On the last …
successful 6 cycles treatment with 177Lu-prostatespecific membrane antigen. On the last …
Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression
E Pirayesh, M Tavakoli - Molecular Imaging and Radionuclide …, 2023 - search.proquest.com
A 66-year old man known case of metastatic castration resistant prostate cancer underwent
successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen. On the last …
successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen. On the last …
Metachronous Brain Tumor in 177Lu-PSMA Scan in a Patient with Metastatic Castration Resistant Prostate Cancer Mimicking Disease Progression.
E Pirayesh, M Tavakoli - Molecular Imaging and Radionuclide …, 2023 - europepmc.org
A 66-year old man known case of metastatic castration resistant prostate cancer underwent
successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen. On the last …
successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen. On the last …